Wet macular degeneration remains among the most dangerous conditions that can threaten eye health. This developing illness may even deprive a person of their central eyesight, ultimately making daily activities such as reading or driving increasingly difficult. Fortunately, recent achievements in medical research have brought about a ray of light to patients with this severe threat to vision: Vascular Endothelial Growth Factor (VEGF) treatment.
Wet macular degeneration, also referred to as neovascular or exudative macular degeneration, is where atypical blood vessels emerge under the retina and then start leaking fluid or blood. This seepage may result in the loss of irreversible damage to the macula; the part of the retina that facilitates clear vision with fine details. In the not so distant past, there were few treatments for wet AMD that simply worked on stopping its progress.
